The white paper on the tendering landscape in Europe outlines how tenders have become essential in pharmaceutical procurement, particularly in Europe, where they account for about 40% of drug purchases. The process, regulated by EU and local regulations, promotes competition, transparency, and cost savings, especially for hospitals, where up to 100% of drug purchases are tendered. Tenders are highly formalized and vary in type, including open, restricted, and negotiated formats. Success in tendering hinges on factors beyond price, including supply reliability, environmental sustainability, and innovation.

Join for free to read